Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Predictors Of Adverse Outcomes In Patients With Hypertrophic Cardiomyopathy: From Ambulatory Care To Advanced Heart Failure

EF 2025-26

Résumé
Hypertrophic cardiomyopathy (HCM) is a common inherited heart condition where the left ventricle becomes abnormally thick and stiff. Many people have mild symptoms, but some progress to a severe “end-stage” form where the heart cannot fill properly. For these patients, a heart transplant is often the only definitive, life-saving treatment. Although HCM patients usually do well in the long run after transplant, they are more likely than other recipients to become unstable during surgery and to have serious early complications in the intensive care unit. Before transplant, HCM patients have extensive testing that includes routine measures of the pressures in the heart and lungs. However, we do not yet know which specific patterns signal that an HCM patient is at high risk of having issues in the operating room or early after transplant. This study will examine adults with HCM who received a heart transplant at the University Health Network. We will analyze a variety of clinical variables that are measures of pressures in the various chambers of heart, as well as indicators of the pumping function of the heart. We will then see whether these measurements predict what happens during surgery or in the intensive care unit. We are particularly interested in how long it takes for patients to recover, need for intensive support, major complications, and survival in the first year. By identifying clear, actionable warning signs, this work will help clinicians recognize high-risk patients, prepare targeted surgical support, and reduce preventable deaths after a heart transplant.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572661
Name
Gramolini Shreya S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predictors Of Adverse Outcomes In Patients With Hypertrophic Cardiomyopathy: From Ambulatory Care To Advanced Heart Failure
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiogenic Shock; Genetics; Heart Failure; Heart Transplant; Hemodynamics; Hypertrophic Cardiomyopathy; Post Transplant Outcomes; Pulmonary Hypertension; Right Heart Catheterization; Vasoplegia
Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited heart condition where the left ventricle becomes abnormally thick and stiff. Many people have mild symptoms, but some progress to a severe “end-stage” form where the heart cannot fill properly. For these patients, a heart transplant is often the only definitive, life-saving treatment. Although HCM patients usually do well in the long run after transplant, they are more likely than other recipients to become unstable during surgery and to have serious early complications in the intensive care unit. Before transplant, HCM patients have extensive testing that includes routine measures of the pressures in the heart and lungs. However, we do not yet know which specific patterns signal that an HCM patient is at high risk of having issues in the operating room or early after transplant. This study will examine adults with HCM who received a heart transplant at the University Health Network. We will analyze a variety of clinical variables that are measures of pressures in the various chambers of heart, as well as indicators of the pumping function of the heart. We will then see whether these measurements predict what happens during surgery or in the intensive care unit. We are particularly interested in how long it takes for patients to recover, need for intensive support, major complications, and survival in the first year. By identifying clear, actionable warning signs, this work will help clinicians recognize high-risk patients, prepare targeted surgical support, and reduce preventable deaths after a heart transplant.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gramolini, Shreya S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~